EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028

Market by Product Type, Industry Verticals, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The European sleep apnea therapeutics and diagnostics market is likely to develop with a CAGR of 6.61% over the forecast duration from 2021 to 2028, states a report by Triton Market Research.


Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this market include:

•           The United Kingdom

•           Germany

•           Spain

•           France

•           Italy

•           Russia

•           Rest of Europe countries

The market in France is driven mainly by the presence of regional players like SEFAM and the favorable reimbursement policies. Before the onset of the pandemic, France was one of the countries in Europe with a higher rate of acceptance for sleep apnea teleconsultations. For instance, as per a study by Pubmed, in May 2018, 78% of the patients preferred telemonitoring. However, 40% of the patients favored telemonitoring as a means to follow-up instead of adherence monitoring.

The market in the United Kingdom is emerging, thanks to the favorable reimbursement landscape, technological developments in sleep apnea devices, and a high adoption of PAP devices & adaptive servo-ventilators for therapy. The lack of medical adherence to therapy, though, majorly restraints the market growth.

However, the country boasts of an extensive distributor channel for various sleep apnea devices. For instance, Intus Healthcare is a major distributor of home sleep testing devices in the country. Users can order the test through the company’s website. Based on the patients’ physiological data, Intus generates a comprehensive report, including for sleep apnea diagnosis, if detected.

Signifier Medical Technologies Limited is a med-tech company that develops and commercializes innovative and non-invasive solutions for patients affected by snoring and sleep-disordered breathing conditions. EXciteOSA is the company’s proprietary therapy, its first and only daytime genioglossal muscle-neurostimulation technology. With proven clinical data from well-recognized, prestigious universities and academic institutions, it provides a safe and effective treatment to the company’s patients. The UK-based company is headquartered in Hammersmith Grove, London.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET

2.2. KEY INSIGHTS

2.3. PORTER'S FIVE FORCES MODEL

2.3.1. BARGAINING POWER OF BUYERS

2.3.2. BARGAINING POWER OF SUPPLIERS

2.3.3. THREAT OF SUBSTITUTE PRODUCTS

2.3.4. THREAT OF NEW ENTRANTS

2.3.5. COMPETITIVE RIVALRY

2.4. LEGAL, POLICY & REGULATORY FRAMEWORK

2.5. SUPPLY CHAIN OUTLOOK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. ACQUISITIONS & MERGERS

2.8.2. NEW PRODUCT LAUNCHES & DEVELOPMENTS

2.8.3. CONTRACTS AND PARTNERSHIPS

2.8.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

2.9. MARKET DRIVERS

2.9.1. AWARENESS RELATED TO THE NEGATIVE IMPACT OF UNTREATED SLEEP APNEA

2.9.2. RISE IN GERIATRIC POPULATION AND OBESITY CASES

2.9.3. DISTURBED SLEEP DUE TO INCREASED USE OF GADGETS AT NIGHT-TIME

2.10. MARKET CHALLENGES

2.10.1. HIGH COST OF SLEEP APNEA DEVICES

2.10.2. UNFAVORABLE REIMBURSEMENT LANDSCAPE

2.10.3. LACK OF PATIENT ADHERENCE TO THE TREATMENT RECOMMENDED

2.11. MARKET OPPORTUNITIES

2.11.1. INCREASING USAGE OF AT-HOME MONITORING DEVICES

2.11.2. ADVANCEMENTS IN TECHNOLOGY

3. EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – BY PRODUCT TYPE

3.1. THERAPEUTICS

3.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES

3.1.2. OXYGEN DEVICES

3.1.3. MASKS AND ACCESSORIES

3.1.4. ORAL APPLIANCES

3.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES

3.2. DIAGNOSTICS AND MONITORING

3.2.1. POLYSOMNOGRAPHY DEVICE (PSG)

3.2.2. OXIMETER

3.2.3. ACTIGRAPHY MONITORING DEVICE

3.2.4. RESPIRATORY POLYGRAPH

3.2.5. SLEEP APNEA SCREENING DEVICE

3.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES

4. EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – BY INDUSTRY VERTICALS

4.1. HOSPITALS & SLEEP LABORATORIES

4.2. HOME CARE SETTINGS

5. GEOGRAPHICAL ANALYSIS – EUROPE

5.1. COUNTRY ANALYSIS

5.1.1. GERMANY

5.1.2. FRANCE

5.1.3. UNITED KINGDOM

5.1.4. ITALY

5.1.5. RUSSIA

5.1.6. SPAIN

5.1.7. REST OF EUROPE

6. COMPETITIVE LANDSCAPE

6.1. BMC MEDICAL CO LTD

6.2. BRAEBON MEDICAL CORPORATION

6.3. CADWELL INDUSTRIES INC

6.4. DEVILBISS HEALTHCARE LLC

6.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

6.6. GE HEALTHCARE (GENERAL ELECTRIC COMPANY)

6.7. INVACARE CORPORATION

6.8. ITAMAR MEDICAL LTD

6.9. KONINKLIJKE PHILIPS NV

6.10. MEDTRONIC PLC

6.11. NIHON KOHDEN CORPORATION

6.12. SIGNIFIER MEDICAL TECHNOLOGIES LIMITED

6.13. RESMED INC

6.14. SMITHS MEDICAL INC

6.15. SOMNOMEDICS GMBH

6.16. TELEFLEX INCORPORATED

6.17. VYAIRE MEDICAL INC

7. RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.1.1. OBJECTIVES OF STUDY

7.1.2. SCOPE OF STUDY

7.2. SOURCES OF DATA

7.2.1. PRIMARY DATA SOURCES

7.2.2. SECONDARY DATA SOURCES

7.3. RESEARCH METHODOLOGY

7.3.1. EVALUATION OF PROPOSED MARKET

7.3.2. IDENTIFICATION OF DATA SOURCES

7.3.3. ASSESSMENT OF MARKET DETERMINANTS

7.3.4. DATA COLLECTION

7.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: ACQUISITIONS & MERGERS

TABLE 4: NEW PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 5: CONTRACTS AND PARTNERSHIPS

TABLE 6: BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

TABLE 7: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 9: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

TABLE 11: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 2: PORTER'S FIVE FORCES MODEL

FIGURE 3: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020 & 2028 (IN %)

FIGURE 4: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS, 2021-2028 (IN $ MILLION)

FIGURE 5: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 6: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND ACCESSORIES, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY ORAL APPLIANCES, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE SERVO VENTILATION (ASV) DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY DIAGNOSTICS AND MONITORING, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY POLYSOMNOGRAPHY DEVICE (PSG), 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY MONITORING DEVICE, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY RESPIRATORY POLYGRAPH, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY SLEEP APNEA SCREENING DEVICE, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY OTHER DIAGNOSTICS AND MONITORING DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)

FIGURE 18: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOSPITALS & SLEEP LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOME CARE SETTINGS, 2021-2028 (IN $ MILLION)

FIGURE 20: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: FRANCE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: UNITED KINGDOM SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 23: ITALY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 24: RUSSIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 25: SPAIN SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: REST OF EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying